Generally speaking, the incidence, prevalence, and manifestation of psoriasis of the skin are similar between the sexes, but the burden of psoriasis is somewhat heavier for women than men, and there ...

Women with psoriasis show shorter drug survival for biologics, including IL-17/23 inhibitors, due to lower satisfaction and more frequent adverse events. The study used the Dutch BioCAPTURE registry ...

The FDA approved icotrokinra for adults and adolescents aged 12 years and older with moderate to severe plaque psoriasis, Johnson & Johnson announced in a press release. Icotrokinra (Icotyde) is the ...

Psoriasis is a skin condition that causes the formation of thick, scaly patches on the body. It’s commonly found on the elbows, knees or scalp but can occur nearly anywhere on the skin. Cold weather ...

Catching psoriasis early is vital for managing the disease effectively and minimizing its impact on your quality of life. Timely intervention can help slow disease progression, alleviate symptoms, and ...